Severe Paediatric Multisystem Inflammatory Syndrome (PIMS) in a 23 months old baby post COVID-19 effectively managed with IVIG and pulse Steroid: Case report 

Abstract Coronavirus disease (COVID-19) in children largely causes mild disease. Some of these recovered children may present with delayed manifestations described as Hyperinflammatory syndrome resembling closely with Kawasaki disease (KD) or Toxic Shock Syndrome (TSS). Timely identification, supportive treatment and treatment with immunomodulatory drugs make a significant difference in the outcome.